Notice of supply difficulties for PegIntron Powder and Solvent for Solution for Injection. See related file.

BASG/AGES PharmMed informs about the internal changeover of the E2B transmission of individual case reports, which was previously done via WebTrader, to gateway operation. The changeover will take place in October. For notifiers who have already…

All eServices offered by BASG / AGES PharmMed will be available via this platform in the future. Currently, the following services can be accessed via the eServices navigation point: Non-interventional studies (NIS) : Public register of all NIS…

A notice from the Dutch government.

The Medicinal Products Import Act 2010, BGBl I 79/2010, came into force on 19.08.2010. Compilation of the scenarios possible according to the law and the forms to be used: AWEG 2010 scenarios import certificates.pdf AWEG 2010 scenarios marketability…

On 18.08.2010, the Medicinal Products Import Act 2010 was published in the Federal Law Gazette, Federal Law Gazette I No. 79/2010 and comes into force on 19.08.2010. The primary objective of the Medicinal Products Import Act is to protect the health…

The Federal Office for Safety in Health Care (BASG) publishes the following statement on "Calcium Supplementation and Myocardial Infarction Risk." It refers to a meta-analysis on the use of calcium as monotherapy for osteoporosis published in the…

Further information: Download guide

Persons who have had a stay in the Netherlands are to be excluded from donation for a period of 6 weeks.

Children's health depends to a large extent on the availability of appropriate medicines. Half of the medicines used to treat 100 million children and adolescents in the EU have not been adequately tested and approved for them. Rather, medicines are…